We are live on ! Find out more
TPA

Trivium Point Advisory Portfolio holdings

AUM $553M
1-Year Est. Return 26.47%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+26.47%
3 Year Est. Return
+86.73%
5 Year Est. Return
+93.38%
10 Year Est. Return
AUM
$370M
AUM Growth
+$23.5M
Cap. Flow
+$14.8M
Cap. Flow %
4%
Top 10 Hldgs %
28.62%
Holding
211
New
30
Increased
83
Reduced
72
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 22.75%
2 Communication Services 14.95%
3 Financials 13.06%
4 Healthcare 8.39%
5 Consumer Discretionary 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
176
DexCom
DXCM
$29B
$271K 0.07%
3,016
+608
+25% +$57.1K
MGK icon
177
Vanguard Mega Cap Growth ETF
MGK
$31.3B
$270K 0.07%
6,515
-435
-6% -$17.9K
DOCU
178
DocuSign
DOCU
$11.1B
$245K 0.07%
+1,208
New +$280K
PHM icon
179
Pultegroup
PHM
$25.2B
$224K 0.06%
+4,272
New +$199K
C icon
180
Citigroup
C
$213B
$221K 0.06%
+3,036
New +$203K
BNDX icon
181
Vanguard Total International Bond ETF
BNDX
$82B
$219K 0.06%
3,828
-106
-3% -$6.12K
VERU icon
182
Veru
VERU
$35.5M
$216K 0.06%
2,000
ORCL icon
183
Oracle
ORCL
$339B
$207K 0.06%
+2,943
New +$191K
SPG icon
184
Simon Property Group
SPG
$76.4B
$206K 0.06%
+1,808
New +$189K
TJX icon
185
TJX Companies
TJX
$179B
$202K 0.05%
+3,055
New +$204K
CHI
186
Calamos Convertible Opportunities and Income Fund
CHI
$968M
$165K 0.04%
11,627
ACHV icon
187
Achieve Life Sciences
ACHV
$633M
$129K 0.03%
+11,100
New +$132K
ENZ
188
DELISTED
Enzo Biochem, Inc.
ENZ
$62K 0.02%
18,000
VIEWW
189
DELISTED
View, Inc. Warrant
VIEWW
$44K 0.01%
25,000
THBRW
190
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
$44K 0.01%
+20,000
New +$57.8K
REED
191
DELISTED
Reeds, Inc. Common Stock
REED
$23K 0.01%
400
FTOCW
192
DELISTED
FTAC Olympus Acquisition Corp. Warrant
FTOCW
$21K 0.01%
+10,000
New +$26.9K
NSH.WS
193
DELISTED
NavSight Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Sto
NSH.WS
$16K ﹤0.01%
+10,000
New +$16.8K
MYPSW
194
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$15K ﹤0.01%
+10,000
New +$22.3K
FGNA.WS
195
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$15K ﹤0.01%
+10,000
New +$16.9K
BREZW
196
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
$7K ﹤0.01%
+10,000
New +$10.5K
CELG.RT
197
Bristol-Myers Squibb Rights
CELG.RT
$165M
$2K ﹤0.01%
10,000
BIP icon
198
Brookfield Infrastructure Partners
BIP
$19.6B
-43,317
Closed -$1.42M
CDLX icon
199
Cardlytics
CDLX
$22.2M
-169
Closed -$244K
CL icon
200
Colgate-Palmolive
CL
$74.8B
-19,844
Closed -$1.62M

Similar funds

Trivium Point Advisory's Q1 2021 Portfolio in Review

As of Q1 2021, Trivium Point Advisory held 211 positions worth $370M, up 6.8% from $346M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trivium Point Advisory deployed $14.8M of net new capital in Q1 2021, opening 30 new positions and adding to 83 existing holdings. Its largest new stake was iShares Core S&P US Value ETF: 35,147 shares worth $2.42M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $1.7M trimmed.

  • Trivium Point Advisory's largest Q1 2021 buy was iShares Core S&P US Value ETF: 35,147 shares worth $2.42M.
  • Trivium Point Advisory added most to iShares Core Universal USD Bond ETF in Q1 2021, an estimated $2.16M increase.
  • Trivium Point Advisory's biggest Q1 2021 reduction was Vanguard Total Bond Market, cutting an estimated $1.7M.
  • Trivium Point Advisory fully exited Unilever in Q1 2021, selling an estimated $1.69M.
  • Trivium Point Advisory's ten largest holdings make up 29% of its $370M portfolio in Q1 2021.
  • Trivium Point Advisory opened 30 new positions and closed 14 in Q1 2021.
  • Trivium Point Advisory's portfolio value rose 6.8% quarter-over-quarter to $370M.

Based on Trivium Point Advisory's 13F filing for Q1 2021, filed 14 May 2021.